DocGo announced its partnership with Spect, a leading provider of comprehensive digital services for eye exam screenings, including diabetic retinopathy. Leveraging Spect’s innovative hand-held retinal cameras, DocGo’s mobile health clinicians now have a more scalable and cost-effective way to bring diabetic retinopathy and other eye disease screening services to patients in their own homes and workplaces. “Annual diabetic eye exams are extremely important for people living with diabetes to ensure necessary treatment is received to protect their vision. Unfortunately, this exam is often skipped or delayed. It’s also one of the hardest HEDIS quality measures for health plans to close. By integrating Spect’s scalable and portable technology into DocGo’s technology and services, we can increase the number of eligible members screened, and help improve patient care and health plan quality ratings,” said Dr. James Powell, CEO of DocGo’s Clinical Practice Group. “Our focus is to maximize the results of each patient interaction we have. By integrating this technology, we can offer in-home diabetic eye exams as part of our comprehensive Annual Wellness Visit or together with other screenings personalized for that patient.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DCGO: